[ad_1]
Al-Marsad Journal – Agencies: The Washington Post, citing knowledgeable sources, reported that U.S. health officials are examining reports indicating the relationship may be stronger than previously thought between Moderna’s vaccine to prevent Covid -19 and the risk of rare heart disease in younger adults, not yet.
The US journal said the review focused on Canadian data indicating that the risks of Moderna vaccine are greater than those of Pfizer-Biontech, especially in men under the age of thirty.
The Washington Post report cited a source as saying it was still too early for regulators to come to a conclusion, and that more work was needed before any recommendation could be made.
For its part, the United States Food and Drug Administration said, “We will not comment on internal meetings or discussions, but we can say that the FDA is fully committed to reviewing data when available to it.” , according to “Reuters”.
The possible review comes just two days after U.S. health officials announced the provision of a third booster dose to Americans starting September 20, fearing that the protection provided by primary vaccines might be less than required in the face of increased infections with the mutated strain. known as (Delta).
Source link
